Collagenase ointment application at 24- versus 48-hour intervals in the treatment of pressure ulcers. A randomised multicentre study

Clinical Drug Investigation

Volumn 19, Issue 6, 2000, Pages 399-407

  Burgos, Angel ^a   Gimenez J ^a   Moreno, E ^a   Campos, J ^b   Ardanaz, J ^b   Talaero, C ^c   Sanz, M ^d   Garcia J ^e   Benito, S ^f   Pastor, S ^f   Hernandez C ^g   Ballesteros, E ^h   Rivera, C ⁱ  

^a Laboratorios Knoll SA   (Spain)

^b Hospital de Sant Gervasi   (Spain)

^c Hospital Doctor Moliner   (Spain)

^d Neurophysiology Service   (Spain)

^e Servicio de Fisioterapia   (Spain)

^f MRI Department   (Spain)

^g Residencia Los Nogales   (Spain)

^h Hospital Juan Grande   (Spain)

ⁱ Grupo de Estudio de Infección en la Atención Primaria de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; IRUXOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECUBITUS; FEMALE; HOSPITALIZATION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OINTMENT; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SKIN NECROSIS; SPAIN; STATISTICAL ANALYSIS; ULCER HEALING;

EID: 0034131409     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200019060-00002     Document Type: Article

References (26)

1. 1. Pressure ulcers. Rockville, MD: Agency for Health Care Policy and Research. Public Health Service/US Department of Health and Human Services, AHCPR Publication no. 95-0652, 1994
2. 2. Barczak CA, Barnett Rim Childs EJ, Bosley LM. Fourth national pressure ulcer prevalence survey. Adv Wound Care 1997; 10: 18-26
3. 3. Meehan M. National pressure ulcer prevalence survey. Adv Wound Care 1994; 7: 27-30
4. 4. Brandeis GH, Morris JN, Nash DJ, et al. The epidemiology and natural history of pressure ulcers in elderly nursing home residents. JAMA 1990; 264: 2905-9
5. 5. Varma AO, Bur Burgatch E, German FM. Debridement of dermal ulcers with collagenase. Surg Gynecol Obstet 1973; 136: 201-2
6. 6. Jung W, Winter H. Considerations for the use of clostridial collagenase in clinical practice. Clin Drug Invest 1998; 15: 245-52
7. 7. Hatz RA, Niedner R, Vansheidt W, et al. Wound healing and wound management. Berlin: Springer-Verlag, 1994
8. 8. Sinclair RD, Ryan TJ. Types of chronic wounds: indications for enzymatic debridement. In: Westerhof W, Vanscheldt W, editors. Proteolytic enzymes and wound healing. Berlin: Springer, 1994
9. 9. Ranzati C, Zahn W, Thom H. Bacterial collagenase and collagen breakdown products exert chemotactic effects in vitro: implication for wound debridement and wound healing. 4th Annual Meeting of the European Tissue Repair Society. Oxford, England, 1994; 25-28 August
10. 10. Herman IM. Stimulation of human keratinocyte migration and proliferation in vitro: insights into the cellular responses to injury and wound healing. Wounds 1996; 8: 33
11. 11. Cortivo R, Radice M, Brun P, et al. Biological activity of human collagen breakdown products of fibroblasts. Wounds 1995; 7: 38A
12. 12. Porres-Reyes BH, Blair HC, Jeffrey JJ, et al. Collagenase production at the border of granulation tissue in a healing wound: macrophage and mesenchymal collagenase production in vivo. Connect Tissue Res 1991; 27: 63
13. 13. Cohen IK, Diegelmann RF, Lindblad WJ, editors. Wound healing: biochemical and clinical aspects. Philadelphia: WB Saunders Company, 1992
14. 14. Peacocke M, Gilchrest B. Cutaneous aging: cellular and molecular studies. In: Abatangelo G, Davidson JM, editors. Cutaneous development, aging and repair. Fidia Research Series. Padova: Liviana Press, 1989
15. 15. Palmieri B, Magri M. A new formulation of collagenase ointment (Iruxol® Mono) in the treatment of ulcers of the lower extremities. A randomised, placebo-controlled, double-blind study. Clin Drug Invest 1998; 15: 381-7
16. 16. Lee LK, Ambrus JL. Collagenase therapy for decubitus ulcers. Geriatrics 1975; 30: 91-8
17. 17. Alfisi M, Ferrante A, Veneziani A, et al. Kollagenasehaltiges Enzympräparat fuer die Wundreiningung bei Ulzera unterschiedlicher Genese. Der Kassenartz 1986; 42: 44-50
18. 18. Helaly P, Vogt E, Schneider G and a Group oif Physicians. Wound healing impairment and topical enzymatic therapy: a multicentre double-blind study. Swiss Med J (Praxis) 1988; 52: 1428-34
19. 19. Van Leen MWF. Collagenase treatment of chronic ulcers. 46° Congresso Nazionale delta Societá Italiana di Chirurgia Plastica Ricostruttiva ed Estetic the European Tissue Repair SocietyFocuseMeeting.Venezi a, 1997;30September-3 October
20. 20. Arnell I. Treating decubitus ulcers: two methods that work. Nursing 1983; 13:50-5
21. 21. Winer BJ, Statistical principles in experimental design. 2nd ed. New York: McGraw Hill, 1997: 261-308
22. 22. Greenhouse SW, Geisser S. On methods in the analysis of profile data. Psychometrika 1959; 24: 95-112
23. 23. Bergstrom N, Braden B. A prospective study of pressure sore risk among institutionalized elderly. J Am Geriatr Soc 1992; 40: 747-58
24. 24. Hanan K, Scheele L. Albumin vs weight as a predictor of nutritional status and pressure ulcer development. Ostomy Wound Manage 1991; 33: 22-7
25. 25. Holmes R, Macchiano K, Jhangani SS, et al. Nutrition Know-how: combating pressure sores nutritionally. Am J Nurs 1987; 87: 1301-3
26. 26. Pinchcofsky-Devin GB, Kaminsky Jr MV. Correlation of pressure sores and nutritional status. J Am Geriatr Soc 1986; 34: 435-40